Dr. Sripal Reddy Palavai Joins BIOVERIC Advisory Board

We are thrilled to announce that Dr. Sripal Reddy Palavai, Ph.D., has joined the BIOVERIC Pharmaceuticals Advisory Board! With more than two decades of experience in analytical development and quality control across R&D and commercial manufacturing at esteemed organizations like Dr. Reddy's Lab, Aurobindo Pharma, and IVERIC bio, Dr. Palavai brings exceptional expertise to our team.

At BIOVERIC Pharmaceuticals, our commitment lies in developing innovative drug products to address unmet patient needs. Dr. Palavai's deep knowledge and experience will be instrumental in driving our mission forward.

Let's warmly welcome Dr. Sripal Reddy Palavai to the BIOVERIC Pharmaceuticals Advisory Board!

BIOVERIC's programs are investigational product candidates. They have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency, and their safety and effectiveness have not been established.